依达拉奉联合川芎嗪治疗脑梗死患者的临床效果观察

吴文斌 ，陈小红

（陕西省扶风县人民医院神经内科，陕西 宝鸡，722200）

浏览次数：102次 下载次数：449次

摘要：

目的 分析依达拉奉联合川芎嗪治疗脑梗死患者的临床效果。方法 选取我院2015年6月至2016年6月收治的76例脑梗死患者为研究对象，根据双盲法将其分为研究组与对照组，各38例。对照组患者给予常规治疗与依达拉奉治疗，研究组患者在对照组基础上联合川芎嗪治疗。对比两组患者的神经功能缺损（NDS）、日常生活能力（ADL）评分及治疗效果。结果 研究组患者NDS评分、ADL评分优于对照组，差异具有统计学意义（P<0.05）；研究组患者的治疗总有效率为97.37%，高于对照 组的73.68%，差异具有统计学意义（P<0.05）。结论 依达拉奉联合川芎嗪治疗脑梗死可显著改善患者的神经功能缺损和日常生活能力，值得临床推广运用。

关键词：依达拉奉；川芎嗪；脑梗死

中图分类号：R743.3文献标志码：A文章编号：2096-1413(2017)26-0016-02

Clinical effect observation of edaravone combined with ligustrazine in the treatment of patients

with cerebral infarction
WU Wen-bin, CHEN Xiao-hong
(Department of Neurology, Fufeng County People``s Hospital, Baoji 722200, China)

ABSTRACT: Objective To analyze the clinical effect of edaravone combined with ligustrazine in the treatment of patients with cerebral infarction. Methods Seventy-six cases of patients with cerebral infarction in our hospital from June 2015 to June 2016 were selected as the study objests. The patients were divided into study group and control group according to double blind method, with 38 cases in each group. Patients in the control group were given routine treatment and edaravone therapy, while the patients in the study group were given ligustrazine treatment based on the control group. The neurological deficit score (NDS), ability of daily living score (ADL) and treatment effect were compared between the two groups. Results The NDS, ADL scores in the study group were significantly better than those in the control group (P< 0.05); the effective rate in the study group was 97.37%, which was higher than 73.68% in the control group (P<0.05).Conclusion The edaravone combined with ligustrazine in the treatment of patients with cerebral infarction can obviosisly improve the neurological deficit and daily life ability, it is worthy of popularization in clinic.
KEYWORDS: edaravone; ligustrazine; cerebral infarction

参考文献：
[1] 胡继川.依达拉奉联合川芎嗪注射液治疗急性脑梗死的临床疗效观察[J].中国现代医学杂志,2013,23(25):76-78.
[2] 刘保萍,边焕茹,王真,等.依达拉奉联合神经节苷脂治疗急性脑梗死临床效果观察[J].中国医药导刊,2013,15(9):2504-2505.
[3] 刘继男.依达拉奉联合早期康复治疗对急性脑梗死患者的临床效果分析[J].中国民康医学,2016,28(11):43-44.
[4] 郝跃跃.依达拉奉联合疏血通治疗急性脑梗死患者的临床效果[J]. 中国药物经济学,2016,11(8):58-59.
[5] 张芳权.依达拉奉联合丁苯肽治疗急性脑梗死患者的早期康复效果观察[J].中国民康医学,2016,28(18):16-17.
[6] 任志学.依达拉奉注射液联合丹参川芎嗪注射液治疗急性脑梗死的临床疗效观察[J].实用心脑肺血管病杂志,2016,24(9):91-93.
[7] 张华,李阳春.血栓通注射液与依达拉奉联合治疗急性脑梗死的临床效果观察[J].中国当代医药,2015,22(4):75-76,79.
[8] 赵家松,陈伟.依达拉奉联合川芎嗪治疗急性脑梗死的临床观察[J].临床医学,2015,35(3):123-124.
[9] 王锦华,陈强,汪东良.老年急性脑梗死患者依达拉奉联合神经节苷脂治疗的临床效果及对炎症因子的影响[J].中华医院感染学杂志,2015,25(10):2179-2181.
[10] 高成森,任小斐,孟祥峰.依达拉奉联合川芎嗪注射液治疗脑梗死临床观察[J].中医临床研究,2014,6(18):20-21.